Warren M. ZAPOL,Kenneth D. BLOCH,Akito NAKAGAWA,Francine E. LUI,Revital FREEDMAN
申请号：
US15111149
公开号：
US20160331782A1
申请日:
2015.01.13
申请国别(地区):
US
年份:
2016
代理人:
摘要：
This invention relates to compounds of Formula I: (Formula I), and pharmaceutically acceptable salt thereof, which are allosteric effectors that increase the oxygen-being affinity of hemoglobin, which are useful in the treatment of sickle cell disease, high altitude tissue hypoxia, and other conditions.
